Evidence map›Paper›PMID 24369008›Full record

Trial reportBioMed research international2013

Baseline obesity status modifies effectiveness of adapted diabetes prevention program lifestyle interventions for weight management in primary care.

Kristen M J Azar, Lan Xiao, Jun Ma

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00842426 (A Pilot of Customized Continuous Care Management of Obesity in Pre-Diabetics), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00842426 phase2completednot on this map

A Pilot of Customized Continuous Care Management of Obesity in Pre-Diabetics

TypeinterventionalSponsorPalo Alto Medical FoundationRan2009 to 2011Enrolled241ConditionsObesity, Pre-diabetes, Metabolic SyndromeArmsSelf-management program (SM), Care management program (CM)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Precision medicine in adult and pediatric obesity: a clinical perspective.Therapeutic advances in endocrinology and metabolism · 2019
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kristen M J AzarPalo Alto Medical Foundation Research Institute, 795 El Camino Real, Ames Building, Palo Alto, CA 94301, USA.
Lan XiaoPalo Alto Medical Foundation Research Institute, 795 El Camino Real, Ames Building, Palo Alto, CA 94301, USA.
Jun MaPalo Alto Medical Foundation Research Institute, 795 El Camino Real, Ames Building, Palo Alto, CA 94301, USA ; Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Funding

A Pilot of Customized Continuous Care Management of Obesity in Pre-DiabeticsR34DK080878 · NIDDK · PALO ALTO MEDICAL FOUNDATION RES INST · PI MA, JUN · 2009 to 2010
$489k
NIDDK NIH HHS R34 DK080878NIDDK NIH HHS R34DK080878
6 · The paper itself

Abstract

objectiveTo examine whether baseline obesity severity modifies the effects of two different, primary care-based, technology-enhanced lifestyle interventions among overweight or obese adults with prediabetes and/or metabolic syndrome. PATIENTS AND

methodsWe compared mean differences in changes from baseline to 15 months in clinical measures of general and central obesity among participants randomized to usual care alone (n = 81) or usual care plus a coach-led group (n = 79) or self-directed individual (n = 81) intervention, stratified by baseline body mass index (BMI) category.

resultsParticipants with baseline BMI 35+ had greater reductions in mean BMI, body weight (as percentage change), and waist circumference in the coach-led group intervention, compared to usual care and the self-directed individual intervention (P < 0.05 for all). In contrast, the self-directed intervention was more effective than usual care only among participants with baseline BMIs between 25 ≤ 35. Mean weight loss exceeded 5% in the coach-led intervention regardless of baseline BMI category, but this was achieved only among self-directed intervention participants with baseline BMIs <35.

conclusionsBaseline BMI may influence behavioral weight-loss treatment effectiveness. Researchers and clinicians should take an individual's baseline BMI into account when developing or recommending lifestyle focused treatment strategy. This trial is registered with ClinicalTrials.gov NCT00842426.

Indexed as

AdultBody CompositionBody Mass IndexDiabetes MellitusFemaleHumansLife StyleMaleMetabolic SyndromeMiddle AgedObesityOverweightWeight Loss

Identifiers

PMID24369008
PMCPMC3867857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.